EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Glutathione-Mediated Neuroprotective Effect of Purine Derivatives

Nobuko Matsumura iD, Koji Aoyama iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241713067 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Nobuko Matsumura und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan. Hauptthemen laut MEDLINE: Alzheimer Disease, Glutathione, Neuroprotection, Neuroprotective Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Urakami Food and Food Culture Promotion Foundation, Urakami Foundation for Food and Food Culture Promotion, Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Numerous basic studies have reported on the neuroprotective properties of several purine derivatives such as caffeine and uric acid (UA). Epidemiological studies have also shown the inverse association of appropriate caffeine intake or serum urate levels with neurodegenerative diseases such as Alzheimer disease (AD) and Parkinson’s disease (PD). The well-established neuroprotective mechanisms of caffeine and UA involve adenosine A2A receptor antagonism and antioxidant activity, respectively. Our recent study found that another purine derivative, paraxanthine, has neuroprotective effects similar to those of caffeine and UA. These purine derivatives can promote neuronal cysteine uptake through excitatory amino acid carrier protein 1 (EAAC1) to increase neuronal glutathione (GSH) levels in the brain. This review summarizes the GSH-mediated neuroprotective effects of purine derivatives. Considering the fact that GSH depletion is a manifestation in the brains of AD and PD patients, administration of purine derivatives may be a new therapeutic approach to prevent or delay the onset of these neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGlutathioneNeuroprotectionNeuroprotective AgentsParkinson DiseasePurinesHumansAdenosine A2 Receptor AntagonistsBrainCysteineExcitatory Amino Acid Transporter 3Receptor, Adenosine A2ATheophyllineUric AcidCaffeine

Stichwörter der Autor:innen

Alzheimer diseaseParkinson’s diseasecaffeinecysteineexcitatory amino acid carrier protein 1glutathionepurine derivativesuric acid

Substanzen

1,7-dimethylxanthineAdenosine A2 Receptor AntagonistsCysteineExcitatory Amino Acid Transporter 3GlutathioneNeuroprotective AgentsPurinesReceptor, Adenosine A2ATheophyllineUric Acid

Autor:innen und Institutionen

  • Department of Pharmacology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan.

ORCID-Profile: Nobuko Matsumura, Koji Aoyama

Förderung

  • Urakami Food and Food Culture Promotion Foundation
  • Urakami Foundation for Food and Food Culture Promotion, Japan

Zitieren

APA

Matsumura, N., & Aoyama, K. (2023). Glutathione-Mediated Neuroprotective Effect of Purine Derivatives. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241713067

Vancouver

Matsumura N, Aoyama K. Glutathione-Mediated Neuroprotective Effect of Purine Derivatives. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241713067

BibTeX
@article{Matsumura2023,
  author = {Matsumura, Nobuko and Aoyama, Koji},
  title = {Glutathione-Mediated Neuroprotective Effect of Purine Derivatives},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241713067}
}
Kostenlos starten →